Rocket Pharmaceuticals is a biotechnology company focused on the development of gene therapies for rare and devastating diseases. Co. has various clinical-stage ex vivo lentiviral vector programs. These include programs for Fanconi Anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells, Leukocyte Adhesion Deficiency-I, a genetic disorder that causes the immune system to malfunction and Pyruvate Kinase Deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. In the U.S., Co. has a clinical stage in vivo adeno-associated virus program for Danon disease. We show 25 historical shares outstanding datapoints in our RCKT shares outstanding history coverage, used to compute RCKT market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing RCKT market cap history over the course of time is important for investors
interested in comparing RCKT's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of RCKT versus a peer is one thing; comparing
RCKT market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like RCKT can fluctuate over the course of history.
With this page we aim to empower investors researching RCKT by allowing them to research the RCKT market cap history. |
Free RCKT Email Alerts:
Video: The Importance of Market Cap
